Ocrevus Zunovo Interactions
There are 512 drugs known to interact with Ocrevus Zunovo (hyaluronidase/ocrelizumab), along with 4 disease interactions. Of the total drug interactions, 44 are major, 391 are moderate, and 77 are minor.
- View all 512 medications that may interact with Ocrevus Zunovo
- View Ocrevus Zunovo disease interactions (4)
Most frequently checked interactions
View interaction reports for Ocrevus Zunovo (hyaluronidase / ocrelizumab) and the medicines listed below.
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- albuterol
- albuterol / ipratropium
- alendronate
- Alhemo (concizumab)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amitriptyline
- amlodipine
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apple cider vinegar
- apremilast
- Aspirin Low Strength (aspirin)
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Eliquis (apixaban)
- Jardiance (empagliflozin)
- ketorolac
- Ocrevus (ocrelizumab)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
Ocrevus Zunovo disease interactions
There are 4 disease interactions with Ocrevus Zunovo (hyaluronidase / ocrelizumab) which include:
Report options
QR code containing a link to this page
More about Ocrevus Zunovo (hyaluronidase / ocrelizumab)
- Ocrevus Zunovo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
